| Establishment of an African green monkey model for COVID-19 and protection against re-infection C Woolsey, V Borisevich, AN Prasad, KN Agans, DJ Deer, NS Dobias, ... Nature immunology 22 (1), 86-98, 2021 | 248 | 2021 |
| Current state of Ebola virus vaccines: A snapshot C Woolsey, TW Geisbert PLoS pathogens 17 (12), e1010078, 2021 | 93 | 2021 |
| Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase RW Cross, KN Agans, AN Prasad, V Borisevich, C Woolsey, DJ Deer, ... Virology journal 17, 1-12, 2020 | 70 | 2020 |
| Transcriptome analysis of circulating immune cell subsets highlight the role of monocytes in Zaire Ebola virus Makona pathogenesis AR Menicucci, K Versteeg, C Woolsey, CE Mire, JB Geisbert, RW Cross, ... Frontiers in immunology 8, 1372, 2017 | 53 | 2017 |
| Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants K Versteeg, AR Menicucci, C Woolsey, CE Mire, JB Geisbert, RW Cross, ... Scientific reports 7 (1), 9730, 2017 | 47 | 2017 |
| An introduction to the Marburg virus vaccine consortium, MARVAC RW Cross, IM Longini, S Becker, K Bok, D Boucher, MW Carroll, JV Díaz, ... PLoS pathogens 18 (10), e1010805, 2022 | 41 | 2022 |
| A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease SL Foster, C Woolsey, V Borisevich, KN Agans, AN Prasad, DJ Deer, ... Proceedings of the National Academy of Sciences 119 (12), e2200065119, 2022 | 39 | 2022 |
| Postexposure efficacy of recombinant vesicular stomatitis virus vectors against high and low doses of Marburg virus variant Angola in nonhuman primates C Woolsey, JB Geisbert, D Matassov, KN Agans, V Borisevich, RW Cross, ... The Journal of infectious diseases 218 (suppl_5), S582-S587, 2018 | 33 | 2018 |
| A VP35 mutant Ebola virus lacks virulence but can elicit protective immunity to wild-type virus challenge C Woolsey, AR Menicucci, RW Cross, P Luthra, KN Agans, V Borisevich, ... Cell reports 28 (12), 3032-3046. e6, 2019 | 32 | 2019 |
| A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge C Woolsey, RW Cross, KN Agans, V Borisevich, DJ Deer, JB Geisbert, ... PLoS neglected tropical diseases 16 (5), e0010433, 2022 | 30 | 2022 |
| A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever RW Cross, C Woolsey, AN Prasad, V Borisevich, KN Agans, DJ Deer, ... Cell reports 40 (3), 2022 | 28 | 2022 |
| Use of convalescent serum reduces severity of COVID-19 in nonhuman primates RW Cross, AN Prasad, V Borisevich, C Woolsey, KN Agans, DJ Deer, ... Cell reports 34 (10), 2021 | 27 | 2021 |
| Resistance of cynomolgus monkeys to Nipah and Hendra virus disease is associated with cell-mediated and humoral immunity AN Prasad, C Woolsey, JB Geisbert, KN Agans, V Borisevich, DJ Deer, ... The Journal of infectious diseases 221 (Supplement_4), S436-S447, 2020 | 26 | 2020 |
| Immune correlates of postexposure vaccine protection against Marburg virus C Woolsey, A Jankeel, D Matassov, JB Geisbert, KN Agans, V Borisevich, ... Scientific reports 10 (1), 3071, 2020 | 25 | 2020 |
| Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques C Woolsey, AC Fears, V Borisevich, KN Agans, NS Dobias, AN Prasad, ... Emerging Microbes & Infections 11 (1), 1635-1646, 2022 | 24 | 2022 |
| Early transcriptional changes within liver, adrenal gland, and lymphoid tissues significantly contribute to ebola virus pathogenesis in cynomolgus macaques A Jankeel, AR Menicucci, C Woolsey, KA Fenton, N Mendoza, K Versteeg, ... Journal of virology 94 (11), 10.1128/jvi. 00250-20, 2020 | 24 | 2020 |
| Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease RW Cross, ZA Bornholdt, AN Prasad, C Woolsey, V Borisevich, KN Agans, ... JCI insight 7 (10), 2022 | 23 | 2022 |
| Bundibugyo ebolavirus Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling C Woolsey, V Borisevich, KN Agans, KA Fenton, RW Cross, TW Geisbert MBio 12 (4), 10.1128/mbio. 01517-21, 2021 | 15 | 2021 |
| Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease C Woolsey, V Borisevich, AC Fears, KN Agans, DJ Deer, AN Prasad, ... The Journal of Clinical Investigation 133 (3), 2023 | 13 | 2023 |
| Establishment of an African green monkey model for COVID-19. bioRxiv. 2020 C Woolsey, V Borisevich, AN Prasad, KN Agans, DJ Deer, NS Dobias, ... Preprint. https://doi. org/10.1101/2020.05 17, 0 | 11 | |